Early markers of gestational diabetes mellitus

Women"s metabolism during pregnancy undergoes numerous changes that can lead to gestational diabetes mellitus (GDM). The cause and pathogenesis of GDM, a heterogeneous disease, are not completely clear, but GDM is increasing in prevalence and is associated with the modern lifestyle. Most diagno...

Full description

Permalink: http://skupni.nsk.hr/Record/nsk.NSK01001163312/Details
Matična publikacija: Biochemia medica (Online)
31 (2021), 3 ; str. 416-430
Glavni autori: Omazić, Jelena (Author), Viljetić, Barbara, Ivić, Vedrana, Kadivnik, Marta, Zibar, Lada, Müller, Andrijana, Wagner, Jasenka
Vrsta građe: e-članak
Jezik: eng
Online pristup: https://doi.org/10.11613/BM.2021.030502
Elektronička verzija članka
Elektronička verzija članka
Elektronička verzija članka
LEADER 02831naa a22004094i 4500
001 NSK01001163312
003 HR-ZaNSK
005 20230213141541.0
006 m d
007 cr||||||||||||
008 230213s2021 ci |o |0|| ||eng
024 7 |2 doi  |a 10.11613/BM.2021.030502 
035 |a (HR-ZaNSK)001163312 
040 |a HR-ZaNSK  |b hrv  |c HR-ZaNSK  |e ppiak 
041 0 |a eng 
042 |a croatica 
044 |a ci  |c hr 
080 1 |2 2011 
100 1 |a Omazić, Jelena  |4 aut  |9 HR-ZaNSK 
245 1 0 |a Early markers of gestational diabetes mellitus :  |h [Elektronička građa]  |b what we know and which way forward? /  |c Jelena Omazić, Barbara Viljetić, Vedrana Ivić, Marta Kadivnik, Lada Zibar, Andrijana Müller, Jasenka Wagner. 
300 |b Ilustr. 
504 |a Bibliografija: 
504 |a Summary. 
520 |a Women"s metabolism during pregnancy undergoes numerous changes that can lead to gestational diabetes mellitus (GDM). The cause and pathogenesis of GDM, a heterogeneous disease, are not completely clear, but GDM is increasing in prevalence and is associated with the modern lifestyle. Most diagnoses of GDM are made via the guidelines from the International Association of Diabetes and Pregnancy Study Groups (IADSPG), which involve an oral glucose tolerance test (OGTT) between 24 and 28 weeks of pregnancy. Diagnosis in this stage of pregnancy can lead to short- and long-term implications for the mother and child. Therefore, there is an urgent need for earlier GDM markers in order to enable prevention and earlier treatment. Routine GDM biomarkers (plasma glucose, insulin, C-peptide, homeostatic model assessment of insulin resistance, and sex hormone-binding globulin) can differentiate between healthy pregnant women and those with GDM but are not suitable for early GDM diagnosis. In this article, we present an overview of the potential early biomarkers for GDM that have been investigated recently. We also present our view of future developments in the laboratory diagnosis of GDM. 
700 1 |a Viljetić, Barbara  |4 aut  |9 HR-ZaNSK 
700 1 |a Ivić, Vedrana  |4 aut  |9 HR-ZaNSK 
700 1 |a Kadivnik, Marta  |4 aut  |9 HR-ZaNSK 
700 1 |a Zibar, Lada  |4 aut  |9 HR-ZaNSK 
700 1 |a Müller, Andrijana  |4 aut  |9 HR-ZaNSK 
700 1 |a Wagner, Jasenka  |4 aut  |9 HR-ZaNSK 
773 0 |t Biochemia medica (Online)  |x 1846-7482  |g 31 (2021), 3 ; str. 416-430  |w nsk.(HR-ZaNSK)000655372 
981 |b Be2021 
856 4 0 |u https://doi.org/10.11613/BM.2021.030502 
856 4 0 |u https://www.biochemia-medica.com/en/journal/31/3/10.11613/BM.2021.030502  |y Elektronička verzija članka 
856 4 0 |u https://www.biochemia-medica.com/en/journal/31/3/10.11613/BM.2021.030502/fullArticle  |y Elektronička verzija članka 
856 4 1 |y Digitalna.nsk.hr 
856 4 0 |u https://hrcak.srce.hr/264024  |y Elektronička verzija članka